Arvinas to Participate in Upcoming Investor Conferences

Posted: June 4, 2024 at 2:49 am

NEW HAVEN, Conn., June 03, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in two upcoming investor conferences:

Read more:
Arvinas to Participate in Upcoming Investor Conferences

Related Posts